Combined apigenin and magnesium (A+M) synergistically enhances sleep duration in normal and insomnia mouse models
In normal mice, A+M treatment increased sleep duration by 44% (p<0.005). In caffeine-induced sleep disturbed mice, sleep duration increased by 32% (p<0.001), and in PCPA-induced insomnia mice, by 37% (p<0.05). These effects surpassed individual treatments of apigenin or magnesium alone.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Combined apigenin and magnesium (A+M) synergistically enhances sleep duration in normal and insomnia mouse models The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 26/100 (low).
The Claim
Combined apigenin and magnesium (A+M) synergistically enhances sleep duration in normal and insomnia mouse models
This conclusion is most relevant to: Normal mice, caffeine-induced sleep disturbed mice, and p-chlorophenylalanine (PCPA)-induced insomnia mice.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models. (Food & function, 2026) —
How It Works
The proposed biological pathway:
- ▸A+M treatment suppresses systemic and hypothalamic TNFα levels in PCPA-induced mice
- ▸A+M treatment inhibits microglial activation
- ▸Inhibition of microglial activation occurs potentially via suppressing NFκB signaling
- ▸Result: Enhanced sleep duration and restored sleep architecture
Who Might Benefit
Evidence fit by population:
- ▸Normal mice, caffeine-induced sleep disturbed mice, and p-chlorophenylalanine (PCPA)-induced insomnia mice
Recommended Dose
N/A (not specified in abstract)
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Animal model study; results may not directly translate to humans
- ▸Dose and ratio of apigenin to magnesium not specified in abstract
- ▸Mechanistic pathway (NFκB) is inferred but not fully established
Frequently Asked Questions
What is the combined effect of apigenin and magnesium on sleep?▼
The combination significantly increases sleep duration in normal mice (44%) and in two insomnia models (32-37%), outperforming either compound alone.
How does apigenin and magnesium improve sleep?▼
The combination suppresses TNFα levels and inhibits microglial activation, potentially through blocking NFκB signaling, which reduces neuroinflammation.
Is this study done on humans?▼
No, this is an animal study using mouse models (normal, caffeine-induced, and PCPA-induced insomnia). Human trials are needed.
What are the limitations of this study?▼
Limitations include the use of animal models, lack of specified doses, and incomplete mechanistic confirmation.
References
- 1.Wong WY, Chan BD, Zhou H, Leung TC, Tai WC. “Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models..” Food & function, 2026. PMID: 41701207 DOI: 10.1039/d5fo04538j